Kewaunee Q1 Earnings Fall Y/Y Despite International Strength
Kewaunee Scientific Corporation (KEQU) reported first-quarter fiscal 2027 results with sales declining 6.7% to $66.3 million and EPS falling to $0.58 from $1.04 year-over-year. The Lab Products Group faced headwinds from challenging life sciences market conditions, though the International segment showed improved profitability through higher-margin project mix. Management remains confident in underlying demand despite extended project timelines amid geopolitical and economic uncertainty.